Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05869487 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Calf Circumference Versus X-ray Absorptiometry in the Diagnosis of Sarcopenia in Elderly Hospitalized Patients

Study acronym: PAPY-SARCM
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Re-verified, no change to tracked fieldsv6
  2. Primary and study completion dates: Apr 2025 to Apr 11, 2027v5
  3. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Nov 2023 to Dec 11, 2023
    • Study site revised
    v4
  4. Enrollment target: 101 to 298v3 Show 4 more changesShow less
    • Primary and study completion dates: Mar 2025 to Apr 2025
    • Start date: Oct 2023 to Nov 2023
    • Study description revised
    • Publications: 2 to 13
  5. Start date: Jun 2023 to Oct 2023
    • Primary and study completion dates: Nov 2024 to Mar 2025
    v2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a prospective single-center study to evaluate a diagnostic method. The main objective of the study is to evaluate the performance of calf circumference as a diagnostic method for sarcopenia in hospitalized elderly people, compared to a gold standard method which is X-ray absorptiometry. The study population are hospitalizing participants aged 75 years and older with an indication to search for sarcopenia.
Trial Details
NCT Number NCT05869487
Lead Sponsor Centre Hospitalier Régional d'Orléans
Conditions
(from sponsor)		 Sarcopenia
Related terms Sarcopenia
Enrollment 298 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov